Satoshi Ichikawa

1.1k total citations
75 papers, 462 citations indexed

About

Satoshi Ichikawa is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Satoshi Ichikawa has authored 75 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 25 papers in Genetics and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Satoshi Ichikawa's work include Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (13 papers). Satoshi Ichikawa is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Chronic Lymphocytic Leukemia Research (16 papers) and Viral-associated cancers and disorders (13 papers). Satoshi Ichikawa collaborates with scholars based in Japan, United States and Germany. Satoshi Ichikawa's co-authors include Hideo Harigae, Noriko Fukuhara, Yasushi Onishi, Ryo Ichinohasama, Tetsuya Fukuda, Kenichi Ishizawa, Yoko Okitsu, Koichi Onodera, Shozo Hirota and Shinichi Matsumoto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Molecular and Cellular Biology.

In The Last Decade

Satoshi Ichikawa

61 papers receiving 444 citations

Peers

Satoshi Ichikawa
Leonardo Campiotti Italy
Umut Dişel Türkiye
Hiroaki Shimizu Japan
G.M. Gandolfo Italy
Shande Tang United States
Toru Kiguchi Japan
Lena Innala Sweden
Michelle Afkhami United States
Nicole A. Carreau United States
G Castelli Italy
Leonardo Campiotti Italy
Satoshi Ichikawa
Citations per year, relative to Satoshi Ichikawa Satoshi Ichikawa (= 1×) peers Leonardo Campiotti

Countries citing papers authored by Satoshi Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Satoshi Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Ichikawa more than expected).

Fields of papers citing papers by Satoshi Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Ichikawa. The network helps show where Satoshi Ichikawa may publish in the future.

Co-authorship network of co-authors of Satoshi Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Ichikawa. A scholar is included among the top collaborators of Satoshi Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Ichikawa. Satoshi Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichikawa, Satoshi, Koichi Onodera, Yoko Okitsu, et al.. (2025). Methotrexate-associated Angioimmunoblastic T-cell Lymphoma Presenting with Acute Kidney Injury. Internal Medicine. 65(1). 167–172.
2.
Ichikawa, Satoshi, Hiroshi Nakamura, Ryo Nakagawa, et al.. (2024). Successful Cord Blood Transplantation for Myeloid/Natural Killer Precursor Acute Leukemia: A Case Report and Literature Review. Internal Medicine. 64(8). 1235–1239.
3.
Yamaguchi, Motoko, Noriko Fukuhara, Jun Takizawa, et al.. (2024). Alemtuzumab monotherapy for T-cell prolymphocytic leukemia: an observational study in Japan. Journal of Clinical and Experimental Hematopathology. 64(3). 216–222.
4.
Ichikawa, Satoshi, Ryo Nakagawa, Shunsuke Hatta, et al.. (2024). Successful Allogeneic Hematopoietic Stem Cell Transplantation for Nodal Epstein-Barr Virus-positive T/NK-cell Lymphoma. Internal Medicine. 64(12). 1888–1892.
5.
6.
Ichikawa, Satoshi, Yasushi Onishi, Noriko Fukuhara, et al.. (2022). Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation. Journal of Clinical and Experimental Hematopathology. 62(3). 164–168.
7.
Fujiwara, Tohru, Koya Ono, Chie Suzuki, et al.. (2022). Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome. Scientific Reports. 12(1). 14562–14562. 14 indexed citations
8.
Izutsu, Koji, Kiyoshi Ando, Daisuke Ennishi, et al.. (2021). Safety and antitumor activity of acalabrutinib for relapsed/refractory B‐cell malignancies: A Japanese phase I study. Cancer Science. 112(6). 2405–2415. 8 indexed citations
9.
Kanamori, Hajime, Satoshi Ichikawa, Noriko Fukuhara, et al.. (2021). Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab. The Lancet Infectious Diseases. 21(5). 741–741. 5 indexed citations
10.
Kuroha, Masatake, Rintaro Moroi, Hisashi Shiga, et al.. (2021). Long-term endoscopic remission in Crohn’s disease after allogeneic hematopoietic stem cell transplantation for diffuse large B cell lymphoma: case report and literature review. Clinical Journal of Gastroenterology. 14(4). 1108–1114.
11.
Ichikawa, Satoshi, Noriko Fukuhara, Ko Hashimoto, et al.. (2021). Anaplastic multiple myeloma with MYC rearrangement. SHILAP Revista de lepidopterología. 17. 100288–100288. 2 indexed citations
12.
Ichikawa, Satoshi, Noriko Fukuhara, Kei Saito, et al.. (2020). Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series. International Journal of Hematology. 111(5). 667–672. 8 indexed citations
13.
Ichikawa, Satoshi, Noriko Fukuhara, Kei Saito, et al.. (2020). Successful Treatment of Primary Refractory Angioimmunoblastic T-cell Lymphoma With Cord Blood Transplantation. Clinical Lymphoma Myeloma & Leukemia. 20(11). e926–e929. 1 indexed citations
14.
Munakata, Wataru, Kiyoshi Ando, Kiyohiko Hatake, et al.. (2019). Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan. Cancer Science. 110(5). 1686–1694. 47 indexed citations
15.
Onishi, Yasushi, Koichi Onodera, Masahiro Kobayashi, et al.. (2018). Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 25(2). e55–e59. 13 indexed citations
16.
Abe, Osamu, et al.. (1999). Thessaloniki Declaration of the Conference on "Educating for a Sustainable Future : A Transdisciplinary Vision for Concerted Action". 8(2). 71–74. 2 indexed citations
17.
Matsumoto, Shinichi, et al.. (1999). Solitary hepatocellular carcinoma fed by the cystic artery: Limitation of transcatheter arterial embolization. CardioVascular and Interventional Radiology. 22(3). 206–209. 13 indexed citations
18.
Matsumoto, Shinichi, et al.. (1997). Simultaneous Thrombolysis of Superior Mesenteric Artery and Bilateral Renal Artery Thromboembolisms with Three Transfemoral Catheters. CardioVascular and Interventional Radiology. 20(5). 397–400. 9 indexed citations
19.
20.
Ichikawa, Satoshi, et al.. (1992). Quality Examination of 7% Lidocaine Cream Prepared in Our Hospital.. Japanese Journal of Hospital Pharmacy. 18(5). 486–490.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonardo Campiotti Breakdown of academic impact, for papers by Umut Dişel Breakdown of academic impact, for papers by Hiroaki Shimizu Breakdown of academic impact, for papers by G.M. Gandolfo Breakdown of academic impact, for papers by Shande Tang Breakdown of academic impact, for papers by Toru Kiguchi Breakdown of academic impact, for papers by Lena Innala Breakdown of academic impact, for papers by Michelle Afkhami Breakdown of academic impact, for papers by Nicole A. Carreau Breakdown of academic impact, for papers by G Castelli
Rankless by CCL
2026